You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Alemtuzumab for the Treatment of T-cell Prolymphocytic Leukemia

ID: 6-22 Jan 2007
Type of Content: Guidelines & Advice, Clinical
Document Status: Archived
Authors:
G. Fraser, A.E. Haynes, C.T. Kouroukis